MIMS Group, Asia’s largest multi-channel provider of drug information, medical communications, events management and marketing services, and Ashfield Healthcare Communications
The immuno-oncology therapy has shown excellent results in various clinical trials and in patients being treated with immune-oncology therapy. Immuno-oncology